Mohamed O Othman MD
Advanced Endoscopic Interventional, Biliary Tract Disease, Pancreas Disease
Professor
Join to View Full Profile
7200 Cambridge St.Suite 8BHouston, TX 77030
Phone+1 713-798-0950
Dr. Othman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mohamed Othman is a gastroenterologist in Houston, TX and is affiliated with multiple hospitals in the area, including Baylor St. Luke's Medical Center and Houston Methodist Hospital. He received his medical degree from Mansoura University Faculty of Medicine and has been in practice 18 years. He specializes in advanced endoscopic interventional, biliary tract disease, and pancreas disease. He has more than 100 publications and over 500 citings.
Education & Training
University of New Mexico School of MedicineFellowship, Gastroenterology, 2007 - 2010- University of New Mexico School of MedicineResidency, Internal Medicine, 2004 - 2007
Mansoura University Faculty of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2023 - 2027
TX State Medical License 2010 - 2026
NM State Medical License 2004 - 2014
American Board of Internal Medicine Gastroenterology
Clinical Trials
- Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD) Start of enrollment: 2016 Dec 12
- ConMed Beamer Study Start of enrollment: 2021 May 27
- Utility of OverStitch Sx After ESD Start of enrollment: 2020 Jul 02
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- RCT comparing the clinical efficacy and costs of two tissue approximation devices in the closure of large post-endoscopic resection defects.Salmaan Jawaid, Mai Khalaf, Fares Ayoub, Noor Zabad, Ahmad Fikry
Surgical Endoscopy. 2025-08-01 - Outcomes and Limitations of Duodenal Endoscopic Submucosal Dissection in the United States.Mai A Khalaf, Fares Ayoub, Tara Keihanian, Allan Zhang, Christina Zelt
Digestive Diseases and Sciences. 2025-07-31 - Clinical Outcomes of Endoscopic Submucosal Dissection for Residual Neoplasia After Incomplete Resection of Large Non-Pedunculated Colorectal Polyps: A Large Multicente...Ernesto Robalino Gonzaga, Yiyang Zhang, Abdul S Mohammed, Baha Aldeen Bani Fawwaz, Aimen Farooq
Gastrointestinal Endoscopy. 2025-07-22
Authored Content
- Tu1409 RECTAL INDOMETHACIN DECREASE THE RISK OF POST-ERCP PANCREATITIS IN CONSECUTIVE PATIENTS. A TERTIARY REFERRAL CENTER EXPERIENCEMay 2018
- Tu1409 RECTAL INDOMETHACIN DECREASE THE RISK OF POST-ERCP PANCREATITIS IN CONSECUTIVE PATIENTS. A TERTIARY REFERRAL CENTER EXPERIENCEMay 2018
Press Mentions
Treating Barrett’s Esophagus: Comparing EMR and ESDMay 1st, 2025- 6 Exocrine Pancreatic Insufficiency Symptoms That Can Cause GI TroubleMarch 23rd, 2022
- Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)March 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
